Search
for
Sort by
Research 721–750 of 1000+
- Expression of concern: potential risk for developing severe COVID-19 disease among anabolic steroid users
- Testosterone target therapy: focus on immune response, controversies and clinical implications in patients with COVID-19 infection
- Pityriasis rosea as a leading manifestation of COVID‐19 infection
- Change of the diagnostic distribution in applicants to dermatology after COVID ‐19 pandemic: What it whispers to us?
- Detection of Male Hypogonadism in Patients with Post COVID-19 Condition
- The effect of canakinumab on clinical outcomes in patients with COVID-19: A meta-analysis
- Do Anti-androgens Have Potential as Therapeutics for COVID-19?
- Weathering the Storm: Harnessing the Resolution of Inflammation to Limit COVID-19 Pathogenesis
- Opportunistic pathogenic fungal co-infections are prevalent in critically ill COVID-19 patients: Are they risk factors for disease severity?
- Patients with bullous skin disease in a high‐epidemic COVID‐19 area, Bergamo, Italy
- Elevated neutralization of Omicron with sera of COVID-19 recovered and breakthrough cases vaccinated with Covaxin than two dose naïve vaccinees
- Rapidly progressive alopecia areata totalis in a COVID‐19 patient, unresponsive to tofacitinib
- Clinical and Laboratory Follow-up After Hospitalization for COVID-19 at an Italian Tertiary Care Center
- Saying no to SARS-CoV-2: the potential of nitric oxide in the treatment of COVID-19 pneumonia
- Oral isotretinoin combined with topical clobetasol 0.05% and tacrolimus 0.1% for the treatment of frontal fibrosing alopecia: a randomized controlled trial
- Roles of steroid receptors in the lung and COVID-19
- Need for a Standardized Translational Drug Development Platform: Lessons Learned from the Repurposing of Drugs for COVID-19
- “MATH+” Multi-Modal Hospital Treatment Protocol for COVID-19 Infection: Clinical and Scientific Rationale
- Shedding light on therapeutics in alopecia and their relevance to COVID-19
- Caution in the time of rashes and COVID-19
- Drug interactions between common dermatological medications and the oral anti-COVID-19 agents nirmatrelvir-ritonavir and molnupiravir
- Efficacy of QR678 Neo<sup>®</sup> hair growth factor formulation for the treatment of hair loss in Covid‐19‐induced persistent Telogen Effluvium—A prospective, clinical, single‐blind study
- Proxalutamide (GT0918) Reduces the Rate of Hospitalization in mild-to-moderate COVID-19 Female Patients: A Randomized Double-Blinded Placebo-Controlled Two-Arm Parallel Trial
- Proxalutamide Reduction of Mortality Rate in Hospitalized COVID-19 Patients Depends on Treatment Duration – an Exploratory Analysis of the Proxa-Rescue AndroCoV Trial
- 5-Alpha-Reductase Inhibitors Reduce Remission Time of COVID-19: Results From a Randomized Double Blind Placebo Controlled Interventional Trial in 130 SARS-CoV-2 Positive Men
- Can hydroxychloroquine be useful in the prevention of COVID-19? An Italian survey in dermatologic and rheumatologic patients already under treatment
- Protective trend of anti-androgen therapy during the COVID-19 pandemic: A meta-analysis
- Meta-analysis of post-traumatic stress disorder and COVID-19 in patients discharged
- Genetic correlation analysis does not associate male pattern baldness with COVID-19
- Fármacos de uso frecuente en dermatología como terapia para COVID-19